Animal models of human prostate cancer

The consensus report of the new york meeting of the mouse models of human cancers consortium prostate pathology committee

Michael Ittmann, Jiaoti Huang, Enrico Radaelli, Philip Martin, Sabina Signoretti, Ruth Sullivan, Brian W. Simons, Jerrold M. Ward, Brian D. Robinson, Gerald C. Chu, Massimo Loda, George Thomas, Alexander Borowsky, Robert D. Cardiff

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Animal models, particularly mouse models, play a central role in the study of the etiology, prevention, and treatment of human prostate cancer. While tissue culture models are extremely useful in understanding the biology of prostate cancer, they cannot recapitulate the complex cellular interactions within the tumor microenvironment that play a key role in cancer initiation and progression. The National Cancer Institute (NCI) Mouse Models of Human Cancers Consortium convened a group of human and veterinary pathologists to review the current animal models of prostate cancer and make recommendations about the pathologic analysis of these models. More than 40 different models with 439 samples were reviewed, including genetically engineered mouse models, xenograft, rat, and canine models. Numerous relevant models have been developed over the past 15 years, and each approach has strengths and weaknesses. Analysis of multiple genetically engineered models has shown that reactive stroma formation is present in all the models developing invasive carcinomas. In addition, numerous models with multiple genetic alterations display aggressive phenotypes characterized by sarcomatoid carcinomas and metastases, which is presumably a histologic manifestation of epithelial-mesenchymal transition. The significant progress in development of improved models of prostate cancer has already accelerated our understanding of thecomplex biology of prostate cancer andpromises to enhance developmentof new approaches to prevention, detection, and treatment of this common malignancy. Cancer Res; 73(9); 2718-36.

Original languageEnglish (US)
Pages (from-to)2718-2736
Number of pages19
JournalCancer Research
Volume73
Issue number9
DOIs
StatePublished - May 1 2013

Fingerprint

Prostatic Neoplasms
Animal Models
Pathology
Neoplasms
Carcinoma
Epithelial-Mesenchymal Transition
Tumor Microenvironment
National Cancer Institute (U.S.)
Heterografts
Canidae
Neoplasm Metastasis
Phenotype
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Animal models of human prostate cancer : The consensus report of the new york meeting of the mouse models of human cancers consortium prostate pathology committee. / Ittmann, Michael; Huang, Jiaoti; Radaelli, Enrico; Martin, Philip; Signoretti, Sabina; Sullivan, Ruth; Simons, Brian W.; Ward, Jerrold M.; Robinson, Brian D.; Chu, Gerald C.; Loda, Massimo; Thomas, George; Borowsky, Alexander; Cardiff, Robert D.

In: Cancer Research, Vol. 73, No. 9, 01.05.2013, p. 2718-2736.

Research output: Contribution to journalArticle

Ittmann, M, Huang, J, Radaelli, E, Martin, P, Signoretti, S, Sullivan, R, Simons, BW, Ward, JM, Robinson, BD, Chu, GC, Loda, M, Thomas, G, Borowsky, A & Cardiff, RD 2013, 'Animal models of human prostate cancer: The consensus report of the new york meeting of the mouse models of human cancers consortium prostate pathology committee', Cancer Research, vol. 73, no. 9, pp. 2718-2736. https://doi.org/10.1158/0008-5472.CAN-12-4213
Ittmann, Michael ; Huang, Jiaoti ; Radaelli, Enrico ; Martin, Philip ; Signoretti, Sabina ; Sullivan, Ruth ; Simons, Brian W. ; Ward, Jerrold M. ; Robinson, Brian D. ; Chu, Gerald C. ; Loda, Massimo ; Thomas, George ; Borowsky, Alexander ; Cardiff, Robert D. / Animal models of human prostate cancer : The consensus report of the new york meeting of the mouse models of human cancers consortium prostate pathology committee. In: Cancer Research. 2013 ; Vol. 73, No. 9. pp. 2718-2736.
@article{83da70cfed4041fc93ef71bbd5a278d3,
title = "Animal models of human prostate cancer: The consensus report of the new york meeting of the mouse models of human cancers consortium prostate pathology committee",
abstract = "Animal models, particularly mouse models, play a central role in the study of the etiology, prevention, and treatment of human prostate cancer. While tissue culture models are extremely useful in understanding the biology of prostate cancer, they cannot recapitulate the complex cellular interactions within the tumor microenvironment that play a key role in cancer initiation and progression. The National Cancer Institute (NCI) Mouse Models of Human Cancers Consortium convened a group of human and veterinary pathologists to review the current animal models of prostate cancer and make recommendations about the pathologic analysis of these models. More than 40 different models with 439 samples were reviewed, including genetically engineered mouse models, xenograft, rat, and canine models. Numerous relevant models have been developed over the past 15 years, and each approach has strengths and weaknesses. Analysis of multiple genetically engineered models has shown that reactive stroma formation is present in all the models developing invasive carcinomas. In addition, numerous models with multiple genetic alterations display aggressive phenotypes characterized by sarcomatoid carcinomas and metastases, which is presumably a histologic manifestation of epithelial-mesenchymal transition. The significant progress in development of improved models of prostate cancer has already accelerated our understanding of thecomplex biology of prostate cancer andpromises to enhance developmentof new approaches to prevention, detection, and treatment of this common malignancy. Cancer Res; 73(9); 2718-36.",
author = "Michael Ittmann and Jiaoti Huang and Enrico Radaelli and Philip Martin and Sabina Signoretti and Ruth Sullivan and Simons, {Brian W.} and Ward, {Jerrold M.} and Robinson, {Brian D.} and Chu, {Gerald C.} and Massimo Loda and George Thomas and Alexander Borowsky and Cardiff, {Robert D.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1158/0008-5472.CAN-12-4213",
language = "English (US)",
volume = "73",
pages = "2718--2736",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Animal models of human prostate cancer

T2 - The consensus report of the new york meeting of the mouse models of human cancers consortium prostate pathology committee

AU - Ittmann, Michael

AU - Huang, Jiaoti

AU - Radaelli, Enrico

AU - Martin, Philip

AU - Signoretti, Sabina

AU - Sullivan, Ruth

AU - Simons, Brian W.

AU - Ward, Jerrold M.

AU - Robinson, Brian D.

AU - Chu, Gerald C.

AU - Loda, Massimo

AU - Thomas, George

AU - Borowsky, Alexander

AU - Cardiff, Robert D.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Animal models, particularly mouse models, play a central role in the study of the etiology, prevention, and treatment of human prostate cancer. While tissue culture models are extremely useful in understanding the biology of prostate cancer, they cannot recapitulate the complex cellular interactions within the tumor microenvironment that play a key role in cancer initiation and progression. The National Cancer Institute (NCI) Mouse Models of Human Cancers Consortium convened a group of human and veterinary pathologists to review the current animal models of prostate cancer and make recommendations about the pathologic analysis of these models. More than 40 different models with 439 samples were reviewed, including genetically engineered mouse models, xenograft, rat, and canine models. Numerous relevant models have been developed over the past 15 years, and each approach has strengths and weaknesses. Analysis of multiple genetically engineered models has shown that reactive stroma formation is present in all the models developing invasive carcinomas. In addition, numerous models with multiple genetic alterations display aggressive phenotypes characterized by sarcomatoid carcinomas and metastases, which is presumably a histologic manifestation of epithelial-mesenchymal transition. The significant progress in development of improved models of prostate cancer has already accelerated our understanding of thecomplex biology of prostate cancer andpromises to enhance developmentof new approaches to prevention, detection, and treatment of this common malignancy. Cancer Res; 73(9); 2718-36.

AB - Animal models, particularly mouse models, play a central role in the study of the etiology, prevention, and treatment of human prostate cancer. While tissue culture models are extremely useful in understanding the biology of prostate cancer, they cannot recapitulate the complex cellular interactions within the tumor microenvironment that play a key role in cancer initiation and progression. The National Cancer Institute (NCI) Mouse Models of Human Cancers Consortium convened a group of human and veterinary pathologists to review the current animal models of prostate cancer and make recommendations about the pathologic analysis of these models. More than 40 different models with 439 samples were reviewed, including genetically engineered mouse models, xenograft, rat, and canine models. Numerous relevant models have been developed over the past 15 years, and each approach has strengths and weaknesses. Analysis of multiple genetically engineered models has shown that reactive stroma formation is present in all the models developing invasive carcinomas. In addition, numerous models with multiple genetic alterations display aggressive phenotypes characterized by sarcomatoid carcinomas and metastases, which is presumably a histologic manifestation of epithelial-mesenchymal transition. The significant progress in development of improved models of prostate cancer has already accelerated our understanding of thecomplex biology of prostate cancer andpromises to enhance developmentof new approaches to prevention, detection, and treatment of this common malignancy. Cancer Res; 73(9); 2718-36.

UR - http://www.scopus.com/inward/record.url?scp=84877785851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877785851&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-4213

DO - 10.1158/0008-5472.CAN-12-4213

M3 - Article

VL - 73

SP - 2718

EP - 2736

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 9

ER -